Article

[NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].

Specijalna bolnica za medicinsku rehabilitaciju, Gajeva 2, 49217 Krapinske Toplice.
Reumatizam 02/2006; 53(1):22-4. pp.22-4
Source: PubMed

ABSTRACT Nonsteroidal anti-inflammatory drugs are the first choice in the tretment of rheumatic diseases. Nonsteroidal-antiinflammatory drugs show high efficacy, but they could be responsible for gastrointestinal and cardiovascular adverse events. When the gastrointestinal risk is generally accepted, cardiovascular risk is still without consensus. Did the discussion about potential cardiovascular risk with nonsteroidal anti-inflammatory drugs influenced their prescription in real life? Data on 201 patients with rheumatoid arthritis show that the prescription of nonselective, nonsteroidal anti-inflammatory drugs remain unchanged. More than two third of the patients use nonsteroidal anti-inflammatory drugs despite they have established cardiovascular disease.

0 0
 · 
0 Bookmarks
 · 
39 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

cardiovascular adverse events
 
cardiovascular disease
 
cardiovascular risk
 
first choice
 
nonsteroidal anti-inflammatory drugs
 
patients use nonsteroidal anti-inflammatory drugs
 
potential cardiovascular risk
 
real life
 
rheumatic diseases
 
rheumatoid arthritis
 
two third